TY - JOUR
AU - Callaghan, Chris J
AU - Curtis, Rebecca M.K.
AU - Mumford, Lisa
AU - Whitaker, Heather
AU - Pettigrew, Gavin J
AU - Gardiner, Dale
AU - Marson, Lorna P
AU - Thorburn, Douglas
AU - White, Steven
AU - Parmer, Jas
AU - Ushiro-Lumb, Ines
AU - Manas, Derek M
AU - Ravanan, Rommel
PY - 2023
DA - January
TI - Vaccine effectiveness against the SARS-CoV-2 B.1.1.529 Omicron variant in solid organ and islet transplant recipients in England: a national retrospective cohort study
JO - Transplantation
DO - https://doi.org/10.1097/TP.0000000000004535
AB - Background The effectiveness of vaccines against the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) B.1.1.529 Omicron variant in immunosuppressed solid organ and islet transplant (SOT) recipients is unclear. Methods National registries in England were linked to identify SARS-CoV-2 positive tests, noninjury hospitalisation within 14 days, and deaths within 28 days between 7 December 2020 and 31 March 2022 in adult SOT recipients. Incidence rate ratios (IRRs) for infection, and hospitalisation or death, were adjusted for recipient demographics and calendar month for the Omicron-dominant period (20 December 2021 to 31 March 2022). Mortality risk following SARS-CoV-2 infection was adjusted for recipient demographics and dominant variant using a Cox proportional-hazards model for the entire time period. Results During the Omicron-dominant period, infection IRRs (95% confidence intervals) were higher in those receiving two, three and four vaccine doses compared to unvaccinated patients (1·25 (1·08-1·45), 1·46 (1·28-1·67), and 1·79 (1·54-2·06), respectively). However, hospitalisation or death IRRs during this period were lower in those receiving three or four vaccine doses compared to unvaccinated patients (0·62 (0·45-0·86) and 0·39 (0·26-0·58), respectively). Risk-adjusted analyses for deaths after SARS-CoV-2 infection between 7 December 2020 to 31 March 2022 found hazard ratios (95% confidence intervals) of 0·67 (0·46-0·98), 0·46 (0·30-0·69), 0·18 (0·09-0·35) for those with two, three, and four vaccine doses, respectively, when compared to the unvaccinated group. Conclusions In immunosuppressed SOT recipients, vaccination is associated with incremental, dose-dependent protection against hospitalisation or death after SARS-CoV-2 infection, including against the Omicron variant.
PB - Wolters Kluwer
UR - https://www.research.ed.ac.uk/en/publications/f1a26d79-661d-4cdf-952e-aaa7945fe09f
KW - Coronavirus (COVID-19)
ER